Cargando…

Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib

Detalles Bibliográficos
Autores principales: Oliveras-Ferraros, Cristina, Cufí, Sílvia, Sauri-Nadal, Tamara, Barco, Sonia Del, Martin-Castillo, Begoña, Vazquez-Martin, Alejandro, Menendez, Javier A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109561/
https://www.ncbi.nlm.nih.gov/pubmed/21349137
http://dx.doi.org/10.1186/bcr2799
_version_ 1782205445057806336
author Oliveras-Ferraros, Cristina
Cufí, Sílvia
Sauri-Nadal, Tamara
Barco, Sonia Del
Martin-Castillo, Begoña
Vazquez-Martin, Alejandro
Menendez, Javier A
author_facet Oliveras-Ferraros, Cristina
Cufí, Sílvia
Sauri-Nadal, Tamara
Barco, Sonia Del
Martin-Castillo, Begoña
Vazquez-Martin, Alejandro
Menendez, Javier A
author_sort Oliveras-Ferraros, Cristina
collection PubMed
description
format Online
Article
Text
id pubmed-3109561
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31095612011-07-24 Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib Oliveras-Ferraros, Cristina Cufí, Sílvia Sauri-Nadal, Tamara Barco, Sonia Del Martin-Castillo, Begoña Vazquez-Martin, Alejandro Menendez, Javier A Breast Cancer Res Letter BioMed Central 2011 2011-01-24 /pmc/articles/PMC3109561/ /pubmed/21349137 http://dx.doi.org/10.1186/bcr2799 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Letter
Oliveras-Ferraros, Cristina
Cufí, Sílvia
Sauri-Nadal, Tamara
Barco, Sonia Del
Martin-Castillo, Begoña
Vazquez-Martin, Alejandro
Menendez, Javier A
Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
title Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
title_full Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
title_fullStr Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
title_full_unstemmed Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
title_short Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib
title_sort circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual her1/her2 tyrosine kinase inhibitor lapatinib
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109561/
https://www.ncbi.nlm.nih.gov/pubmed/21349137
http://dx.doi.org/10.1186/bcr2799
work_keys_str_mv AT oliverasferraroscristina circulatingfattyacidsynthaseanexploratorybiomarkertopredictefficacyofthedualher1her2tyrosinekinaseinhibitorlapatinib
AT cufisilvia circulatingfattyacidsynthaseanexploratorybiomarkertopredictefficacyofthedualher1her2tyrosinekinaseinhibitorlapatinib
AT saurinadaltamara circulatingfattyacidsynthaseanexploratorybiomarkertopredictefficacyofthedualher1her2tyrosinekinaseinhibitorlapatinib
AT barcosoniadel circulatingfattyacidsynthaseanexploratorybiomarkertopredictefficacyofthedualher1her2tyrosinekinaseinhibitorlapatinib
AT martincastillobegona circulatingfattyacidsynthaseanexploratorybiomarkertopredictefficacyofthedualher1her2tyrosinekinaseinhibitorlapatinib
AT vazquezmartinalejandro circulatingfattyacidsynthaseanexploratorybiomarkertopredictefficacyofthedualher1her2tyrosinekinaseinhibitorlapatinib
AT menendezjaviera circulatingfattyacidsynthaseanexploratorybiomarkertopredictefficacyofthedualher1her2tyrosinekinaseinhibitorlapatinib